Related Experiment Video
Updated: Dec 10, 2025

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization
Published on: August 16, 2015
Cell Cycle Checkpoints Cooperate to Suppress DNA- and RNA-Associated Molecular Pattern Recognition and Anti-Tumor
Jie Chen1, Shane M Harding1, Ramakrishnan Natesan1
1Department of Cancer Biology, Penn Center for Genome Integrity, Basser Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Abstract:
The DNA-dependent pattern recognition receptor, cGAS (cyclic GMP-AMP synthase), mediates communication between the DNA damage and the immune responses. Mitotic chromosome missegregation stimulates cGAS activity; however, it is unclear whether progression through mitosis is required for cancercell-intrinsic activation of anti-tumor immune responses. Moreover, it is unknown whether cell cycle checkpoint disruption can restore responses in cancer cells that are recalcitrant to DNAdamage-induced inflammation. Here, we demonstrate that prolonged cell cycle arrest at the G2-mitosis boundary from either excessive DNA damage or CDK1 inhibition prevents inflammatory-stimulated gene expression and immune-mediated destruction of distal tumors. Remarkably, DNAdamage-induced inflammatory signaling is restored in a RIG-I-dependent manner upon concomitant disruption of p53 and the G2 checkpoint. These findings link aberrant cell progression and p53 loss to an expanded spectrum of damage-associated molecular pattern recognition and have implications for the design of rational approaches to augment anti-tumor immune responses.
Insights
Cell cycle arrest prevents anti-tumor immunity. Disrupting p53 and G2 checkpoints restores DNA damage signaling and immune responses in cancer cells, aiding immunotherapy design.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Cyclic GMP-AMP synthase (cGAS) links DNA damage to immune responses.
- Mitotic errors activate cGAS, but its role in cancer cell-intrinsic immunity is unclear.
- Restoring inflammation in resistant cancer cells via checkpoint disruption is unknown.
Purpose of the Study:
- Investigate if mitosis progression is required for cancer cell-intrinsic anti-tumor immunity.
- Determine if cell cycle checkpoint disruption can restore DNA damage-induced inflammation in resistant cancer cells.
Main Methods:
- Studied the effect of prolonged G2-mitosis arrest (via DNA damage or CDK1 inhibition) on inflammatory gene expression and anti-tumor immunity.
- Assessed restoration of DNA damage-induced inflammatory signaling upon p53 and G2 checkpoint disruption.
- Investigated the role of RIG-I in restored inflammatory signaling.
Main Results:
- Prolonged G2-mitosis arrest inhibits inflammatory gene expression and immune-mediated tumor destruction.
- Concomitant disruption of p53 and the G2 checkpoint restores DNA damage-induced inflammatory signaling.
- Restoration of inflammatory signaling is RIG-I dependent.
Conclusions:
- Aberrant cell cycle progression and p53 loss expand damage-associated molecular pattern recognition.
- Findings suggest strategies to enhance anti-tumor immune responses by targeting cell cycle checkpoints and p53.
- Links cell cycle control to immune evasion in cancer.
Related Concept Videos
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity

